Fajardo, J., Cummings, A., Brown, E., Cuomo, K., Rhodes, P., Woodbury, S., … Judge, D. (2019). Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction. Amyloid, 26(sup1), 166–167. https://doi.org/10.1080/13506129.2019.1583178

Fajardo, Johana, Abby Cummings, Emily Brown, Kimberly Cuomo, Parker Rhodes, Sarah Woodbury, Nisha Gilotra, Stuart Russell, and Daniel Judge. “Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction.” Amyloid 26, no. sup1 (2019): 166–67. https://doi.org/10.1080/13506129.2019.1583178.

Fajardo J, Cummings A, Brown E, Cuomo K, Rhodes P, Woodbury S, et al. Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction. Amyloid. 2019;26(sup1):166–7.

Fajardo, Johana, et al. “Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction.” Amyloid, vol. 26, no. sup1, 2019, pp. 166–67. Pubmed, doi:10.1080/13506129.2019.1583178.

Fajardo J, Cummings A, Brown E, Cuomo K, Rhodes P, Woodbury S, Gilotra N, Russell S, Judge D. Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction. Amyloid. 2019;26(sup1):166–167.